Hysteroscopy Procedures Market Summary

The global hysteroscopy procedures market size was estimated at USD 13.90 billion in 2024 and is projected to reach USD 18.98 billion by 2030, growing at a CAGR of 5.21 percent from 2025 to 2030. This growth is largely driven by the rising prevalence of gynecological disorders, including uterine abnormalities, abnormal uterine bleeding, uterine fibroids, polyps, and a range of fertility-related conditions. As these disorders become increasingly common across various age groups, the demand for diagnostic and operative hysteroscopy continues to expand.

In addition to rising disease prevalence, growing patient preference for minimally invasive surgeries over conventional surgical methods is significantly boosting market adoption. Minimally invasive hysteroscopy offers advantages such as reduced pain, shorter recovery times, and lower risk of complications, making it an appealing option for patients and healthcare providers alike. Technological advancements in hysteroscopy devices, including improved visualization systems, enhanced operative tools, and better integration with digital platforms, are further supporting market growth by improving procedural accuracy and clinical outcomes.

The increasing incidence of uterine cancer has also contributed to a higher number of hysteroscopy procedures. In the United States, endometrial cancer, which affects the lining of the uterus, remains the most common cancer among female reproductive organs, escalating the need for early diagnosis and effective treatment through hysteroscopic evaluation.

Key Market Trends & Insights

• North America led the global hysteroscopy procedures market, holding a revenue share of 38.2 percent in 2024. This dominance can be attributed to advanced healthcare infrastructure, high awareness among patients, and the availability of skilled specialists.
• By CPT code, the 58558 CPT code segment accounted for the largest revenue share of 34.8 percent in 2024, driven by the wide utilization of this code for common diagnostic and operative hysteroscopy procedures.
• By end use, the hospitals segment led the market with the highest revenue share of 52.4 percent in 2024, reflecting the preference for hospital-based treatment due to comprehensive medical facilities and the availability of advanced equipment.

Order a free sample PDF of the Hysteroscopy Procedures Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 13.90 billion
• 2030 Projected Market Size: USD 18.98 billion
• CAGR (2025-2030): 5.21%
• North America: Largest market in 2024

Key Companies & Market Share Insights

The competitive scenario in the hysteroscopy procedures market is highly competitive, with key players such as Medtronic, Stryker Corp., and Hologic, Inc. holding significant positions. The major companies are undertaking various organic as well as inorganic strategies such as new product development, collaborations, acquisitions, mergers, and regional expansion to serve the unmet needs of their customers.

Key Players

• Medtronic
• Stryker Corp.
• Hologic, Inc.
• KARL STORZ SE & Co. KG
• Medical Devices Business Services, Inc. (Ethicon, Inc.)
• Olympus Corp.
• Delmont Imaging
• Braun Melsungen AG
• Richard Wolf GmbH
• CooperCompanies
• Maxer Endoscopy GmbH
• Boston Scientific Corp.
• MedGyn Products, Inc.
• Lina Medical APS
• Luminelle

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The hysteroscopy procedures market is expanding steadily as the prevalence of gynecological disorders rises and the need for accurate, minimally invasive diagnostic solutions grows. Technological advancements continue to improve the precision, safety, and efficiency of hysteroscopy, supporting broader adoption worldwide. With uterine and endometrial cancer cases increasing, demand for early detection and intervention is expected to remain strong throughout the forecast period. As hospitals and healthcare centers invest in advanced hysteroscopy equipment and patient awareness continues to rise, the market is well positioned for sustained growth, reaching higher global adoption by 2030.